Switch to:
More From Other Websites
Why BioCryst Pharmaceuticals Stock Caught Fire Today May 25 2017
Shire to Participate at the Jefferies Healthcare Conference May 25 2017
Ultragenyx Receives Priority Review for rhGUS from FDA May 24 2017
Shire and tiny Lexington biotech say hemophilia drug trial misses mark May 22 2017
Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug May 19 2017
Company News for May 19, 2017 May 19 2017
Blog Coverage: Shire's Stock Price Jumped on Positive Results in Hereditary Angioedema Treatment May 19 2017
Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More May 19 2017
Shire to Highlight New Research Into Chronic Hypoparathyroidism at the European Congress of... May 19 2017
Drugmaker Leads Industry Gains Thursday On Rare Disease Trial May 18 2017
[$$] Biotech Investor Clarus Ventures Raising $880 Million Fund May 18 2017
Shire's swelling disorder drug moves closer to U.S. approval May 18 2017
​Shire gains $2B in market cap as rare disease drug aces late-stage trial May 18 2017
The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing... May 18 2017
Shire ADRs jump almost 7% premarket after positive trial of Angioedema treatment May 18 2017
Shire's Investigational Treatment Lanadelumab Reduces Hereditary Angioedema Monthly Attack Rate by... May 18 2017
[$$] Health-Care Investor Agent Capital Seeks $100 Million Fund May 16 2017
Shire Continues 20-Year Commitment to ADHD with New Research at 2017 Annual Meeting of American... May 16 2017
ETFs with exposure to Shire Plc : May 15, 2017 May 15 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK